The short- and long-term outcomes in living-donor liver transplantation using small-for-size graft: A systematic review and meta-analysis

IF 3.6 2区 医学 Q2 IMMUNOLOGY
Ki-Hun Kim, Sang-Hoon Kim, Hwui-Dong Cho
{"title":"The short- and long-term outcomes in living-donor liver transplantation using small-for-size graft: A systematic review and meta-analysis","authors":"Ki-Hun Kim,&nbsp;Sang-Hoon Kim,&nbsp;Hwui-Dong Cho","doi":"10.1016/j.trre.2023.100747","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>A standard graft-to-recipient weight ratio (GRWR) ≥0.8% is widely accepted in living-donor liver transplantation (LDLT); however, the potential donor pool is expanded to patients adopting small-for-size graft (SFSGs) with GRWR &lt;0.8%. This study aimed to investigate the effect of SFSG on short- and long-term outcomes following LDLT.</p></div><div><h3>Methods</h3><p>Electronic databases were searched from January 1995 to January 2022 for studies comparing short- or long-term outcomes between patients with SFSG (GRWR &lt;0.8%, SFSG group) and sufficient volume graft (GRWR ≥0.8%, non-SFSG group). The primary outcomes were one-, three-, and five-year overall survival (OS) and graft survival<span> (GS), while the secondary outcome was postoperative complications.</span></p></div><div><h3>Results</h3><p>Twenty-four studies comprising 7996 patients were included. In terms of OS, SFSG group had poor three-year OS (HR: 1.48, 95% CI [1.01, 2.15], <em>p</em> = 0.04), but there were no significant differences between two groups in one-year OS (HR: 1.50, 95% CI [0.98, 2.29], <em>p</em> = 0.06) and five-year OS (HR: 1.40, 95% CI [0.95, 2.08], <em>p</em> = 0.02). In GS, there were no significant differences in one-year (HR 1.31, 95% CI [1.00, 1.72], <em>p</em> = 0.05), three-year (HR 1.33, 95% CI [0.97, 1.82], <em>p</em> = 0.07), and five-year GS (HR 1.17, 95% CI [0.95, 1.44], <em>p</em> = 0.13). The SFSG group had comparable postoperative complications, except for a high incidence of vascular complications and small-for-size syndromes.</p></div><div><h3>Conclusions</h3><p>Expanding the potential donor pool in LDLT to SFSG with GRWR &lt;0.8% can be acceptable in terms of comparable long-term OS and GS, despite the risk for vascular complications and small-for-size syndrome.</p></div>","PeriodicalId":48973,"journal":{"name":"Transplantation Reviews","volume":"37 1","pages":"Article 100747"},"PeriodicalIF":3.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955470X23000010","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Background

A standard graft-to-recipient weight ratio (GRWR) ≥0.8% is widely accepted in living-donor liver transplantation (LDLT); however, the potential donor pool is expanded to patients adopting small-for-size graft (SFSGs) with GRWR <0.8%. This study aimed to investigate the effect of SFSG on short- and long-term outcomes following LDLT.

Methods

Electronic databases were searched from January 1995 to January 2022 for studies comparing short- or long-term outcomes between patients with SFSG (GRWR <0.8%, SFSG group) and sufficient volume graft (GRWR ≥0.8%, non-SFSG group). The primary outcomes were one-, three-, and five-year overall survival (OS) and graft survival (GS), while the secondary outcome was postoperative complications.

Results

Twenty-four studies comprising 7996 patients were included. In terms of OS, SFSG group had poor three-year OS (HR: 1.48, 95% CI [1.01, 2.15], p = 0.04), but there were no significant differences between two groups in one-year OS (HR: 1.50, 95% CI [0.98, 2.29], p = 0.06) and five-year OS (HR: 1.40, 95% CI [0.95, 2.08], p = 0.02). In GS, there were no significant differences in one-year (HR 1.31, 95% CI [1.00, 1.72], p = 0.05), three-year (HR 1.33, 95% CI [0.97, 1.82], p = 0.07), and five-year GS (HR 1.17, 95% CI [0.95, 1.44], p = 0.13). The SFSG group had comparable postoperative complications, except for a high incidence of vascular complications and small-for-size syndromes.

Conclusions

Expanding the potential donor pool in LDLT to SFSG with GRWR <0.8% can be acceptable in terms of comparable long-term OS and GS, despite the risk for vascular complications and small-for-size syndrome.

使用小尺寸移植物的活体肝移植的短期和长期结果:系统回顾和荟萃分析
背景标准移植物与受体重量比≥0.8%在活体供肝移植(LDLT)中被广泛接受;然而,潜在的供体库扩展到采用GRWR<;0.8%。本研究旨在调查SFSG对LDLT后短期和长期结果的影响。方法检索1995年1月至2022年1月的电子数据库,比较SFSG患者(GRWR<0.8%,SFSG组)和足够体积移植物(GRWR≥0.8%,非SFSG组。主要结果是一年、三年和五年总生存率(OS)和移植物生存率(GS),而次要结果是术后并发症。结果纳入了24项研究,共7996名患者。就OS而言,SFSG组的三年OS较差(HR:1.48,95%CI[1.01,2.15],p=0.04),但两组在一年OS(HR:1.50,95%CI[0.98,2.29],p=0.06)和五年OS(HR:1.40,95%CI[0.95,2.08],p=0.02)方面无显著差异。在GS中,一年OS无显著差异(HR 1.31,95%CI[1.00,1.72],p=0.05),三年期(HR 1.33,95%CI[0.97,1.82],p=0.07)和五年期GS(HR 1.17,95%CI=0.95,1.44],p=0.013)。除血管并发症发生率高和体积小综合征外,SFSG组的术后并发症相似。结论利用GRWR<;0.8%的长期OS和GS是可以接受的,尽管有血管并发症和小尺寸综合征的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transplantation Reviews
Transplantation Reviews IMMUNOLOGY-TRANSPLANTATION
CiteScore
7.50
自引率
2.50%
发文量
40
审稿时长
29 days
期刊介绍: Transplantation Reviews contains state-of-the-art review articles on both clinical and experimental transplantation. The journal features invited articles by authorities in immunology, transplantation medicine and surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信